Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization With Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting Insights From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial at the 5-Year Follow-Up

Iqbal Javaid; Zhang Yao-Jun; Holmes David R.; Morice Marie-Claude; Mack Michael J.; Kappetein Arie Pieter; Feldman Ted; Stahle Elizabeth; Escaned Javier; Banning Adrian P.; Gunn Julian P.; Colombo Antonio; Steyerberg Ewout W.; Mohr Friedrich W.; Serruys Patrick W.

首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization With Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting Insights From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial at the 5-Year Follow-Up

【24h】

Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization With Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting Insights From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial at the 5-Year Follow-Up

机译：最佳的药物治疗改善了经皮冠状动脉介入治疗或冠状动脉旁路移植术进行血管重建术的患者的临床疗效，这是在5年的随访中，TAXUS经皮冠状动脉介入治疗与心脏外科手术（SYNTAX）协同作用的结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background-There is a paucity of data on the use of optimal medical therapy (OMT) in patients with complex coronary artery disease undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting (CABG) and its long-term prognostic significance.

机译：背景-关于在经皮冠状动脉介入治疗或冠状动脉搭桥术（CABG）进行血运重建的复杂冠状动脉疾病患者中使用最佳药物治疗（OMT）的数据很少，并且其长期预后意义不佳。

著录项

来源
《Circulation: An Official Journal of the American Heart Association》 |2015年第14期|共9页
作者
Iqbal Javaid; Zhang Yao-Jun; Holmes David R.; Morice Marie-Claude; Mack Michael J.; Kappetein Arie Pieter; Feldman Ted; Stahle Elizabeth; Escaned Javier; Banning Adrian P.; Gunn Julian P.; Colombo Antonio; Steyerberg Ewout W.; Mohr Friedrich W.; Serruys Patrick W.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
coronary artery bypass; coronary artery disease; stents;

机译：冠状动脉搭桥;冠状动脉疾病;支架;

相似文献

外文文献
中文文献
专利

1. Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization With Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting Insights From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial at the 5-Year Follow-Up [J] . Iqbal Javaid, Zhang Yao-Jun, Holmes David R., Circulation: An Official Journal of the American Heart Association . 2015,第14期

机译：最佳的药物治疗改善了经皮冠状动脉介入治疗或冠状动脉旁路移植术进行血管重建术的患者的临床疗效，这是在5年的随访中，TAXUS经皮冠状动脉介入治疗与心脏外科手术（SYNTAX）协同作用的结果
2. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. [J] . Morice MC, Serruys PW, Kappetein AP, Circulation: An Official Journal of the American Heart Association . 2010,第24期

机译：TAXUS经皮冠状动脉介入治疗与心脏外科手术之间的协同作用试验中，使用紫杉醇洗脱支架经皮冠状动脉介入治疗或使用冠状动脉搭桥术治疗的左新发主要疾病患者的结局。
3. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: A substudy of the SYNTAX trial (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) [J] . GirasisC., FarooqV., DilettiR., JACC. Cardiovascular interventions . 2013,第12期

机译：三维分叉角对左主冠状动脉疾病经皮冠状动脉介入治疗后5年结局的影响：SYNTAX试验的一项子研究（红豆杉经皮冠状动脉介入治疗与心脏外科手术的协同作用）
4. 18-Month Outcome After Percutaneous Intervention in Post-Coronary Artery Bypass Graft Patients [C] . J. Garcia-Tejada, M. Velazquez, F. Hernandez, International Congress on Coronary Artery Disease . 2007

机译：在冠状动脉后旁路接枝患者中经皮干预后18个月的结果
5. Factors responsible for loss to follow up in a longitudinal study compaing coronary artery bypass surgery and percutaneous coronary intervention . [D] . Vera, Orlando, Jr. 2010

机译：因素损失的后续追踪研究比较冠状动脉搭桥手术和经皮冠状动脉介入治疗。
6. Predictive Ability of the SYNergy Between Percutaneous Coronary Intervention with TAXus and Cardiac Surgery Score II for Long-term Mortality in Patients with Three-vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Treated with Second-generation Drug-eluting Stents [O] . Ji-Qiang He, Xian-Peng Yu, Cheng Peng, 2015

机译：经第二代药物洗脱支架治疗的经皮冠状动脉介入治疗的三支冠状动脉疾病三血管冠状动脉疾病患者经皮冠状动脉介入治疗TAXus与心脏手术评分II的长期死亡率协同作用的预测能力
7. Letter by Uretsky Regarding Article, “Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial” [O] . Barry F. Uretsky 2011

机译：苏塞茨基州关于文章的信，“患者患者患者的结果，患有紫杉醇洗脱支架的经皮冠状动脉介入或冠状动脉旁路移植接枝治疗，在经皮冠状动脉介入与紫杉孢涎和心脏手术（语法）试验中的协同作用中的协同作用中”
8. Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Grafting for Coronary Artery Disease. Executive Summary. Effective Health Care Program Research Report No. 9 [R] . 2007

机译：经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗冠心病的疗效比较。执行摘要。有效的医疗保健计划研究报告第9号

摘要

著录项

相似文献

相关主题

期刊订阅